Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Low-Level Laser Therapy and Photobiomodulation for Tinnitus and Sudden Sensorineural Hearing Loss: A Systematic Review

Overall, LLLT and PBM appear to offer meaningful short-term relief of tinnitus symptoms and modest improvements in hearing thresholds for selected patients, although their long-term efficacy remains uncertain.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This systematic review of nine clinical studies reports that low-level laser therapy and photobiomodulation were associated with short-term reductions in tinnitus severity and handicap, with benefits often diminishing after three to six months. The authors report modest audiometric gains mainly in moderate hearing loss and describe the treatments as safe and well-tolerated, but long-term efficacy remains uncertain.

Studies included
9
Who or what was studied
Patients with tinnitus and sudden sensorineural hearing loss
Limits stated in the abstract
The abstract notes variability in treatment parameters and outcome measures, and states that high-quality randomized trials are needed.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Tinnitus and sudden sensorineural hearing loss (SSNHL) are prevalent otologic disorders that can severely affect quality of life. Low-level laser therapy (LLLT) and photobiomodulation (PBM) have been proposed as potential treatments aimed at enhancing cochlear microcirculation and cellular metabolism; however, their clinical efficacy remains uncertain. This systematic review evaluated the effectiveness of LLLT and PBM in improving tinnitus severity and hearing outcomes among patients with tinnitus and SSNHL. A comprehensive search was conducted in PubMed, Scopus, Web of Science, and the Cochrane Library from inception to September 2025. Eligible studies included randomized controlled trials, quasi-experimental designs, and pre-post studies in humans, published in English, that investigated LLLT or PBM for these conditions. Methodological quality was assessed using the Downs and Black 28-item checklist. Nine clinical studies met the inclusion criteria. Most demonstrated short-term reductions in tinnitus severity and handicap immediately following treatment, with several reporting superiority over placebo or control groups. However, these benefits often diminished after three to six months in longitudinal follow-ups. Audiometric improvements were mainly observed in participants with moderate hearing loss, whereas minimal changes occurred in severe cases. Across all studies, LLLT and PBM were reported to be safe and well-tolerated. Overall, LLLT and PBM appear to offer meaningful short-term relief of tinnitus symptoms and modest improvements in hearing thresholds for selected patients, although their long-term efficacy remains uncertain. Variability in treatment parameters and outcome measures underscores the need for standardized protocols and high-quality randomized trials to support evidence-based clinical recommendations.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Low-level laser therapy, Photobiomodulation, Tinnitus, Systematic review, Laser. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies